Atrial Fibrillation (Part 2) - Catheter Ablation

Overview

Journal Arq Bras Cardiol

Specialty Cardiology & Vascular Diseases

Date 2021 Mar 3

PMID 33656085

Citations 1

Authors

Eduardo B Saad

Andre dAvila

Affiliations

Soon will be listed here.

Abstract

More than 20 years since its initial use, catheter ablation has become a routinely performed procedure for the treatment of patients with atrial fibrillation (AF). Initially based on the electrical isolation of pulmonary veins in patients with paroxysmal AF, subsequent advances in the understanding of pathophysiology led to additional techniques not only to achieve better results, but also to treat patients with persistent forms of arrhythmia, as well as patients with structural heart disease and heart failure.

Citing Articles

Impact of Pulsed Field Ablation on Atrial Fibrillation.

Scanavacca M, Pisani C Arq Bras Cardiol. 2024; 121(10):e20240565.

PMID: 39570162 PMC: 11634214. DOI: 10.36660/abc.20240565.

References

Goette A, Kalman J, Aguinaga L, Akar J, Cabrera J, Chen S . EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. Heart Rhythm. 2016; 14(1):e3-e40. PMC: 5548137. DOI: 10.1016/j.hrthm.2016.05.028. View

Di Biase L, Burkhardt J, Mohanty P, Mohanty S, Sanchez J, Trivedi C . Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation: BELIEF Trial. J Am Coll Cardiol. 2016; 68(18):1929-1940. DOI: 10.1016/j.jacc.2016.07.770. View

Packer D, Mark D, Robb R, Monahan K, Bahnson T, Poole J . Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019; 321(13):1261-1274. PMC: 6450284. DOI: 10.1001/jama.2019.0693. View

Kuck K, Merkely B, Zahn R, Arentz T, Seidl K, Schluter M . Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial. Circ Arrhythm Electrophysiol. 2019; 12(12):e007731. DOI: 10.1161/CIRCEP.119.007731. View

Iwasawa J, Koruth J, Mittnacht A, Tran V, Palaniswamy C, Sharma D . The impact of mechanical oesophageal deviation on posterior wall pulmonary vein reconnection. Europace. 2019; 22(2):232-239. DOI: 10.1093/europace/euz303. View

Hunter R, Berriman T, Diab I, Kamdar R, Richmond L, Baker V . A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014; 7(1):31-8. DOI: 10.1161/CIRCEP.113.000806. View

Bunch T, May H, Bair T, Johnson D, Weiss J, Crandall B . Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes. Heart Rhythm. 2013; 10(9):1257-62. DOI: 10.1016/j.hrthm.2013.05.013. View

Saad E, Costa I, Costa R, Inacio Jr L, Slater C, Camiletti A . Safety of ablation for atrial fibrillation with therapeutic INR: comparison with transition to low-molecular-weight heparin. Arq Bras Cardiol. 2011; 97(4):289-96. DOI: 10.1590/s0066-782x2011005000088. View

Hayashi K, An Y, Nagashima M, Hiroshima K, Ohe M, Makihara Y . Importance of nonpulmonary vein foci in catheter ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2015; 12(9):1918-24. DOI: 10.1016/j.hrthm.2015.05.003. View

10.

Wilber D, Pappone C, Neuzil P, de Paola A, Marchlinski F, Natale A . Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010; 303(4):333-40. DOI: 10.1001/jama.2009.2029. View

11.

Della Rocca D, Mohanty S, Trivedi C, Di Biase L, Natale A . Percutaneous Treatment of Non-paroxysmal Atrial Fibrillation: A Paradigm Shift from Pulmonary Vein to Non-pulmonary Vein Trigger Ablation?. Arrhythm Electrophysiol Rev. 2018; 7(4):256-260. PMC: 6304790. DOI: 10.15420/aer.2018.56.2. View

12.

Mateos J, Mateos E, Pena T, Lobo T, Pachon Mateos J, Vargas R . Simplified method for esophagus protection during radiofrequency catheter ablation of atrial fibrillation--prospective study of 704 cases. Rev Bras Cir Cardiovasc. 2015; 30(2):139-47. PMC: 4462958. DOI: 10.5935/1678-9741.20150009. View

13.

Bunch T, Crandall B, Weiss J, May H, Bair T, Osborn J . Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011; 22(8):839-45. DOI: 10.1111/j.1540-8167.2011.02035.x. View

14.

Khaykin Y, Marrouche N, Martin D, Saliba W, Schweikert R, Wexman M . Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses. J Cardiovasc Electrophysiol. 2004; 15(7):784-9. DOI: 10.1046/j.1540-8167.2004.03279.x. View

15.

Steinberg J, Palekar R, Sichrovsky T, Arshad A, Preminger M, Musat D . Very long-term outcome after initially successful catheter ablation of atrial fibrillation. Heart Rhythm. 2014; 11(5):771-6. DOI: 10.1016/j.hrthm.2014.02.003. View

16.

Morillo C, Verma A, Connolly S, Kuck K, Nair G, Champagne J . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014; 311(7):692-700. DOI: 10.1001/jama.2014.467. View

17.

De Vasconcelos J, Galvao Filho S, Atie J, Maciel W, de Souza O, Saad E . Atrial-oesophageal fistula following percutaneous radiofrequency catheter ablation of atrial fibrillation: the risk still persists. Europace. 2017; 19(2):250-258. DOI: 10.1093/europace/euw284. View

18.

Go A, Reynolds K, Yang J, Gupta N, Lenane J, Sung S . Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation: The KP-RHYTHM Study. JAMA Cardiol. 2018; 3(7):601-608. PMC: 6145663. DOI: 10.1001/jamacardio.2018.1176. View

19.

Leshem E, Zilberman I, Tschabrunn C, Barkagan M, Contreras-Valdes F, Govari A . High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization. JACC Clin Electrophysiol. 2018; 4(4):467-479. DOI: 10.1016/j.jacep.2017.11.018. View

20.

Lobo T, Pachon C, Pachon J, Pachon E, Pachon M, Pachon J . Atrial fibrillation ablation in systolic dysfunction: clinical and echocardiographic outcomes. Arq Bras Cardiol. 2014; 104(1):45-52. PMC: 4387610. DOI: 10.5935/abc.20140167. View